Thermo Fisher opened a new bioanalytical lab in Sweden, expanding its PPD Laboratory Services network. This enhances GLP-capable support for global drug development, especially in complex cell and gene therapies. The move strengthens its role as an end-to-end partner for pharma and biotech, potentially driving long-term revenue growth and shareholder value.